1 To Inject the Dose Of Medication
Christi Crummer edited this page 1 month ago


Home diabetes therapy requires the affected person to perform a prescribed regimen that involves self-testing at-home blood monitoring glucose levels and administering an applicable dose of insulin. Insulin has historically been injected by a hypodermic syringe, which suffers from numerous drawbacks. For instance, syringes usually are not preloaded with medication, requiring the user to hold a separate medical vial. Syringes also require a degree of dexterity and sufficient visual acuity on the part of the affected person to line up the needle of the syringe with the rubber septum on the medical vial and at-home blood monitoring to make sure that the syringe is loaded with the proper dosage. In consequence, BloodVitals test unintentional needle pricks generally occur. Such delivery pens use prepackaged insulin and may be used repeatedly till the treatment is exhausted. Mechanical and digital pens are available to the affected person. Glucose ranges are monitored at periodic intervals to determine when one other insulin injection must be taken or to find out how the consumer is responding to prior injections.


To watch glucose levels the patient is required to have obtainable a lancer, check strips and a blood glucose monitor. U.S. Patent No. 5,279,294 to Anderson et al. The monitor at-home blood monitoring and lancer are built-in in the housing. The lancer just isn't an unbiased part operably distinct from the housing. Rather, the housing features a spring-actuated hammer for at-home blood monitoring driving a disposable lancet. For the reason that lancer is built-in with the housing, it can't be eliminated and used individually from the housing. U.S. Patent No. 5,536,249 to Castellano et al. The pen and monitor BloodVitals SPO2 are not independent units and thus cannot be used separately from one another. FIGS. 1-three reveals an exemplary embodiment of a diagnostic and medication delivery system a hundred constructed in accordance with the present invention. One hundred conveniently integrates a medication delivery pen, blood glucose monitor, and lancer into a single portable unit. 102 could have an general rectangular footprint and the higher and decrease surfaces 116 and 118 could also be planar or, alternatively, at-home blood monitoring may have either concave or convex curvatures.


The curvatures of the higher and lower surfaces 116 and painless SPO2 testing 118 need not match each other. 102 provides mounting locations for a medication supply pen, lancer, and glucose monitoring meter. 104 is configured to obtain a lancer 108 so that the lancer engages and slides within the lancer compartment in a manner that allows it to be simply inserted and eliminated. 106 is configured to obtain a treatment delivery pen 110. When inserted in their respective compartments, a portion of the body of the lancer and painless SPO2 testing pen are uncovered so that they're readily accessible to the user. 102 during which the lancet of the lancer and the needle of the pen are to be situated. 102 supplies safety to the needle of the pen, eliminating the necessity for a separate pen cap. A hundred and ten could also be of any kind recognized to those of extraordinary skill in the art. To inject the dose of medication, the person inserts the needle underneath the skin and depresses the knob once as far as it'll depress.


The information will be displayed on a show positioned on the pen. 126 to a computer or at-home blood monitoring other electronic storage machine in order that it could also be subsequently reviewed by the person or a well being skilled. 126 to put in, for instance, updated software program. Examples of medicine delivery pens that may be employed in the present invention are disclosed in U.S. 108 may be of any type recognized to these of odd talent within the artwork. 108 will sometimes include an actuator such as a button for actuating a mechanism that displaces a disposable lancet. The mechanism also returns the lancet to its preliminary place after it has been inserted into the finger of the user. 124 positioned on the housing 102 is coupled to the digital circuitry for BloodVitals health transferring knowledge to or from an exterior device resembling a pc, cellphone jack or a communication network. 106 the display shows the blood glucose data.